Authorized Generics: Why Mylan Would Compete With Itself in the EpiPen Market As part of an attempt to quell the furor over its more than 400% price increase for its life-saving EpiPen, Mylan ...
The US Food and Drug Administration (FDA) announced Thursday that it has denied Mylan’s petition that sought to block certain generic applications for Advair (fluticasone propionate and salmeterol).
The CAFC also affirmed the district court’s ruling that Actelion failed to prove infringement by an equivalent, according to ipwatchdog.com. The report went on to say that Actelion further argued that ...
NEW YORK, March 27 (Reuters) - Mylan Laboratories Inc. appeared set to have exclusive rights to sell generic versions of Pfizer Inc.'s Norvasc blood-pressure drug until at least April 13 after a U.S.
PITTSBURGH — Mylan has launched a generic drug for fungal infections, the company said Tuesday. Mylan announced the launch, through subsidiary Mylan Pharmaceuticals, of voriconazole tablets in the ...
In its latest effort to defend against forthcoming Entresto copycats, Novartis is taking to U.S. federal court to allege infringement against several generics players. In a new lawsuit, Novartis sued ...
Generic drug maker Mylan received final FDA approval for a generic version of Pfizer’s blockbuster blood-pressure medicine Norvasc. Mylan said in a statement that since it was the first generic ...
Generic drugmaker Mylan Pharmaceuticals Inc. has received FDA approval to begin shipping a generic version of a drug that treats gallstones. Ursodia USP is a bile acid that naturally occurs in the ...
The Canonsburg, Pa.-based drugmaker will sell a two-pack of the generic epinephrine auto-injectors for $300, a more than 50 percent discount from EpiPen’s $608 list price. Mylan has faced intense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results